Remove Communication Remove Hospitals Remove Pharmaceutical Manufacturing
article thumbnail

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

article thumbnail

Navigating 340B Program Changes in 2025

Proxsys Rx

Maximizing pharmacys role in your hospitals revenue cycle The 340B landscape continues to evolve rapidly, with ongoing manufacturer restrictions, new compliance hurdles, and increasing financial pressures on covered entities. Recent estimates indicate that hospitals and clinics collectively lose around $3.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy. Sign up for our daily news round-up!

article thumbnail

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3

Express Pharma

This event led to criminal convictions and highlighted the deadly consequences of GMP fraud in sterile manufacturing. Teva Pharmaceuticals IV Saline Contamination (USA, 2008) Contaminated sodium chloride IV solutions resulted in fatal endotoxin reactions in hospitalized patients. FDA oversight.

article thumbnail

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

article thumbnail

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Pharmacy Times

Designed to manage patients with complex, chronic neurological conditions such as multiple sclerosis (MS), epilepsy, migraine, and movement disorders, the model aims to enhance medication access, streamline communication, and improve clinical outcomes. 1 Evidence from recent studies supports the effectiveness of this approach.